Related Experiment Video

Updated: Jun 12, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K

An urgent case for measles vaccination in Gaza

Ronald Waldman1, Robert Steinglass2, Phillip Nieburg3

  • 1Milken Institute School of Public Health, George Washington University, Washington, DC 20037, USA.

Lancet (London, England)
|September 23, 2024
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.2K
Measurement of γHV68 Infection in Mice
13:22

Measurement of γHV68 Infection in Mice

Published on: November 22, 2011

13.6K

Related Experiment Videos

Last Updated: Jun 12, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.2K
Measurement of γHV68 Infection in Mice
13:22

Measurement of γHV68 Infection in Mice

Published on: November 22, 2011

13.6K

Related Concept Videos

Vaccinations01:51

Vaccinations

44.1K
Overview
44.1K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

919
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
919

Articles linked to this work by shared authors, journal, and citation graph.

Polio: Background and perspective on how international travel can be made safe against polio.

Therapeutic advances in infectious disease·2024

The respiratory route of transmission of virulent polioviruses.

Infectious diseases (London, England)·2024

Controlled temperature chain for vaccination in low- and middle-income countries: a realist evidence synthesis.

Bulletin of the World Health Organization·2022

A systematic review of effective strategies for chronic disease management in humanitarian settings; opportunities and challenges.

Preventive medicine·2022

Sustaining Maternal and Neonatal Tetanus Elimination (MNTE) in countries that have been validated for elimination - progress and challenges.

BMC public health·2022

Linked vaccination coverage surveys plus serosurveys among Ethiopian toddlers undertaken three years apart to compare coverage and serologic evidence of protection in districts implementing the RED-QI approach.

Vaccine·2021

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Rapid glycolytic metabolism underpins mucosal-associated invariant T cell functional responses to innate cytokines.

Journal of immunology (Baltimore, Md. : 1950)·2026

RAVEN: Robust, generalizable, multi-resolution structural MRI upsampling using autoencoders.

Imaging neuroscience (Cambridge, Mass.)·2026

MA Dental Plan Enrollment And Generosity Increased, But Continuity Of Coverage Declined, 2010-25.

Health affairs (Project Hope)·2026

Aerobiology and Transmission of Mycobacterium tuberculosis.

Cold Spring Harbor perspectives in medicine·2026

Advancing the measurement of favorable selection in Medicare Advantage: evidence from encounter data.

Health affairs scholar·2026

MALAT1/miR-146a/COX-2 Expression Profile Six Months After Myocardial Infarction and Association of MALAT1 rs3200401 and miR-146a rs2910164 with Disease Susceptibility.

Biomedicines·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us